Abstract.A study of acute respiratory disease in horses in Ontario was undertaken to determine the identity of current causative infectious agents. A nasopharyngeal swab was designed and utilized to maximize isolation of viruses, mycoplasma, and pathogenic bacteria. Serum samples were collected for parallel determination of antibody titers to equine influenza virus type A subtype 1 (H7N7) and subtype 2 (H3N8), equine rhinovirus types 1 and 2, equine herpesvirus type 1, Mycoplasma equirhinius, and Mycoplasma felis. Equine rhinovirus type 2 was recovered from 28/92 horses tested, and equine influenza virus type A, subtype 2, was recovered from 5. The mycoplasma and bacteria isolated were consistent with those commonly associated with nonspecific respiratory diseases in horses, except that Streptococcus pneumoniae capsular type 3 was isolated from 10 horses.Contagious respiratory infections in horses are major causes of both acute and chronic respiratory diseases resulting in impaired pulmonary function and reduced performance. 12,13,39 The chronic sequelae are important to the horse industry and include bronchopneumonia, chronic obstructive pulmonary disease, and exerciseinduced hemorrhage. 26,39 Earlier studies conducted in Ontario on thoroughbred 8 and standardbred horses used isolation and serodiagnosis to demonstrate that equine influenza virus type A subtypes 1 (AE1; H7N7) and 2 (AE2; H3N8), equine rhinovirus types 1 (ERhV-1) and 2 (ERhV-2), and equine rhinopneumonitis virus, now termed equine herpesvirus type 4 (EHV-4), were the major causes of respiratory disease. Other infectious agents that can induce respiratory disease in the horse are equine abortion virus 1 (distinguished as equine herpesvirus type 1 [EHV-1] 33 ), equine cytomegalovirus (equine herpesvirus type 2 10 ), equine arteritis virus (EAV), 34 equine adenovirus, 14,26 equine rhinovirus-3, 26 mycoplasmas, 16,40 and bacteria. 18,22 Vaccines are currently available in Ontario only for AE1, AE2, EHV-1, EHV-4, and EAV. These viral agents are believed to be the most common causes of clinical respiratory disease in North America. 26 Received for publication March 18, 1996. cious vaccination for AE1, 39 AE2, 39 EHV-1 , 24 and EHV-4 24 using modern vaccines. This continuing disease problem may be due to partial vaccine-induced immunity, genetic diversity of 26 or the antigenic drift of influenza viruses. 13,26,39 This study was conducted to identify the infectious agents more recently implicated in respiratory disease in horses in Ontario . 37 We used patient data, clinical examination, isolation, and paired serology for specific infectious agents. Nasal swabs from 92 horses with acute clinical respiratory disease from 29 different premises were cultured for viruses, mycoplasma, and pathogenic bacteria. Paired sera were collected and tested for antibodies to AE1, AE2, ERhV-1, ERhV-2, and EHV-1. For an additional 89 horses from 13 stables where respiratory disease occurred annually, these same serologic tests and antibody tests for EAV were perf...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.